Trials / Unknown
UnknownNCT04988165
Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese Medicine
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pyrotinib is an important drug for the treatment of breast cancer, but the incidence of diarrhea is very high. At present, there is no particularly effective drug for diarrhea induced by pyrotinib. Trying to intervene with traditional Chinese medicine may bring better results to patients.
Detailed description
Pyrotinib is an important drug for the treatment of breast cancer, but the incidence of diarrhea is very high. At present, there is no particularly effective drug for diarrhea induced by pyrotinib. Trying to intervene with traditional Chinese medicine may bring better results to patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Traditional Chinese Medicine | It is a common prescription used in traditional Chinese medicine to treat diarrhea with remarkable efficacy. |
Timeline
- Start date
- 2021-10-08
- Primary completion
- 2022-10-08
- Completion
- 2022-10-08
- First posted
- 2021-08-03
- Last updated
- 2021-08-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04988165. Inclusion in this directory is not an endorsement.